CIMETIDINE-INDUCED SEIZURES IN MICE - ANTAGONISM BY SOME GABAERGIC AGENTS

被引:28
作者
AMABEOKU, GJ
CHIKUNI, O
机构
关键词
D O I
10.1016/0006-2952(93)90606-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of muscimol, aminooxyacetic acid (AOAA), diamino-n-butyric acid (DABA), baclofen, bicuculline, picrotoxin, strychnine, diazepam, phenobarbitone and phenytoin on cimetidine induced seizures were studied in mice. Cimetidine (400-1000 mg/kg, i.p.) induced dose-dependent tonic convulsion. Muscimol, AOAA and DABA effectively protected mice against cimetidine-induced seizures. Bicuculline and picrotoxin significantly potentiated the seizures induced by cimetidine and effectively antagonized the protective e:ffects of muscimol, AOAA and DABA against the seizures. Diazepam and phenobarbitone significantly protected the mice against cimetidine-induced seizures while phenytoin and strychnine did not significantly alter the seizures. These results indicate that the attenuation of central gamma-aminobutyric acid neurotransmission may underlie cimetidine-induced seizures in mice.
引用
收藏
页码:2171 / 2175
页数:5
相关论文
共 23 条
[1]  
AUTRET E, 1984, ARCH FR PEDIATR, V41, P729
[2]  
BEIN HJ, 1972, SPASTICITY TOPICAL S, P76
[3]   BACLOFEN AS AN ANTICONVULSANT IN EXPERIMENTAL-MODELS OF CONVULSIONS [J].
BENEDITO, MAC ;
LEITE, JR .
EXPERIMENTAL NEUROLOGY, 1981, 72 (02) :346-351
[4]   STUDIES ON EFFECTS OF HISTAMINERGIC AGENTS ON SEIZURE SUSCEPTIBILITY IN MICE [J].
GERALD, MC ;
RICHTER, NA .
PSYCHOPHARMACOLOGIA, 1976, 46 (03) :277-282
[5]  
HORTON RW, 1989, NEUROTRANSMITTERS DR, P165
[6]   UPTAKE AND METABOLISM OF GAMMA-AMINOBUTYRIC ACID BY NEURONS AND GLIAL CELLS [J].
IVERSEN, LL ;
KELLY, JS .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (09) :933-938
[7]  
KADAR D, 1985, PRINCIPLES MED PHARM, P375
[8]  
KATZUNG BG, 1989, BASIC CLIN PHARM, P331
[9]   BACLOFEN (BETA-PARA-CHLOROPHENYL-GAMMA-AMINOBUTYRIC ACID) ENHANCES [GAMMA-AMINOBUTYRIC-H-3 ACID (H-3-GABA) RELEASE FROM RAT GLOBUS PALLIDUS INVITRO [J].
KERWIN, R ;
PYCOCK, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (10) :622-627
[10]  
Lloyd K.G., 1985, PRINCIPLES MED PHARM, P235